GlaxoSmithKline (GSK) Reports Q1 EPS of GBP0.20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
GlaxoSmithKline (GSK) Receives Positive CHMP Opinion on Umbipro as Umbilical Cord Infection Treatment
April 29, 2016 8:23 AM EDTOn 28 April 2016, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion in accordance with Article 58 of Regulation (EC) No 726/20041 for the medicinal product Umbipro, intended for the prophylaxis of omphalitis (infection of the umbilical cord) in newborn infants. This medicinal product has been developed by GlaxoSmithKline... More
